# Marvell Technology, Inc. (MRV.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Pharmaceuticals. Price C$36.20, market value C$32.5 billion.

## Valuation
- **P/E (trailing): 8.7×**. Marvell Technology, Inc. trades at 8.7× trailing earnings. The Healthcare median in the September 2026 study was 28.5×.
- **Price / sales: 2.9×**. Each dollar of revenue is priced at 2.9×.
- **Price / book: 1.2×**. The shares trade at 1.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 5.7×**. Enterprise value is 5.7× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 5.8%**. Free cash flow equals 5.8% of the market value. Above 5% is generally attractive.
- **Earnings yield: 11.5%**. The inverse of the P/E: 11.5% of the price is earned each year.

## Profitability
- **Gross margin: 51.0%**. Marvell Technology, Inc. keeps 51.0% of revenue after the direct cost of what it sells.
- **Operating margin: 16.3%**. 16.3% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 32.6%**. 32.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 18.7%**. 18.7% on shareholders' equity is solid.
- **Return on invested capital: 7.1%**. Return on all capital, debt included, is 7.1%.
- **Return on assets: 12.0%**. Each dollar of assets produces 12.0% of profit.

## Growth
- **EPS growth (1 yr): 248.1%** (5-yr 103.5%/yr). Earnings per share rose 248.1%.
- **Free-cash-flow growth (3 yr): 841.0%/yr**. Free cash flow has compounded at 841.0% a year over three years.

## Financial health
- **Debt to equity: 0.33**. Debt is 0.33 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.5×**. It would take 0.5 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 6.6×**. Operating profit covers interest 6.6× over, a safe margin.
- **Current ratio: 2.01** (quick 1.58). Current assets cover the next year's liabilities 2.01 times.
- **Altman Z-score: 3.15**. A Z-score of 3.15 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.66%** (C$0.24 per share, trailing). Marvell Technology, Inc. yields 0.66%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 8%** (15% of free cash flow). 8% of earnings goes out as dividends, leaving room to keep raising it.
- **Shareholder yield: 8.9%**. Dividends plus net buybacks return 8.9% of the market value a year.

## Price and momentum
- **From 52-week high: -32.7%** (39.2% above the low). Trading 33% below its 52-week high, deep in a drawdown.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 4.03** (volatility 115%). Beta of 4.03 against the S&P/TSX Composite: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MRV.TO · Page: https://foliofundamentals.com/stocks/mrv.to

Not investment advice.